AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$0.96 USD
-0.01 (-1.06%)
Updated Aug 23, 2024 03:59 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Brokerage Reports
0 items in cart
AEON Biopharma, Inc. [AEON]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: AEON Biopharma, Inc.
Industry: Unclassified
Saving Costs And Seeking Funding To Support Program Development; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Awaiting Announcement Of Next Steps; Lower PT to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Sideswiped by Another High Placebo Rate Obscures the Path Forward; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Alignment With FDA Charts Path Forward in Chronic and Episodic Migraine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
ABP-450 Shows Impressive Effect in Treating Episodic Migraine
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Aeon Looks Poised to Disrupt the Blockbuster Neurotoxin Market; Initiate at Buy With $18 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|